Patents expiring in 2026

US 7126008

Carvedilol

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 24 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7125892

Aryl aniline β2 adrenergic receptor agonists

Theravance, Inc. · Granted Tue Oct 24 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7125965

MRI probes of membrane potential

The Regents of the University of California · Granted Tue Oct 24 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7125866

Therapeutic applications of pro-apoptotic benzodiazepines

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 24 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7125845

Aza-peptide macrocyclic hepatitis C serine protease inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Oct 24 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7125541

Combined methods for tumor vasculature targeting and tumor treatment with radiotherapy

THE UNIVERSTY OF TEXAS SYSTEM,BOARD OF REGENTS · Granted Tue Oct 24 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7125857

Modulators of DNA cytosine-5 methyltransferase and methods for use thereof

The Regents of the University of California · Granted Tue Oct 24 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

DK 1007053

Behandling af smerte

AMARIN NEUROSCIENCE LTD [GB] · Granted Mon Oct 30 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Sun Oct 25 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7129052

Peptides and their utility in modulation of behavior of cells expressing α3β1 integrins

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 31 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7129332

Anti-EGFRvIII scFvs with improved cytotoxicity and yield, immunotoxins based thereon, and methods of use thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 31 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7129342

Infectious cDNA clone of GB virus B and uses thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 31 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7129358

Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1H-benzimidazoles

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 31 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7128904

Material containing metal ion ligand complex producing nitric oxide in contact with blood

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 31 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7128894

Contrast enhancing solution for use in confocal microscopy

United States Department of Energy · Granted Tue Oct 31 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7128895

Use of bile acid derivatives conjugated with metal ion chelated complexes for the diagnostic assessment of microvascular permeability

The Regents of the University of California · Granted Tue Oct 31 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7129039

Unique dendritic cell-associated C-type lectins, dectin-1 and dectin-2; compositions and uses thereof

The Board of Regents of the University of Texas System · Granted Tue Oct 31 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7129221

6,11-bicyclic erythromycin derivatives

Enanta Pharmaceuticals, Inc. · Granted Tue Oct 31 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7132547

Preventives/remedies for urinary disturbance

Takeda Pharmaceutical Company Limited · Granted Tue Nov 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7132420

Aspartic protease inhibitors

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7132271

Methods for enhancing the production of viral vaccines in cell culture

The Regents of the University of California · Granted Tue Nov 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7132392

Inhibition of cell motility and angiogenesis by inhibitors of Grb2-SH2-domain

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

BR PI0414331

método de destruição de bactéria numa área de tratamento do paciente e composição antimicrobiana de terapia fotodinámica

CERAMOPTECL IND INC [US] · Granted Tue Nov 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7132102

Bacteriocins and novel bacterial strains

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Nov 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7132403

Antihelminthic anthraquinones and method of use thereof

The Regents of the University of California · Granted Tue Nov 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7132122

Direct micro-patterning of lipid bilayers using UV light and selected uses thereof

The Regents of the University of California · Granted Tue Nov 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7132109

Using heat shock proteins to increase immune response

University of Connecticut Health Center · Granted Tue Nov 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7132422

Sodium channel modulators

Theravance, Inc. · Granted Tue Nov 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7132454

HEXIM1 as a suppressor of HIV replication and cardiac hypertrophy

The Regents of the University of California · Granted Tue Nov 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7135177

Immunoliposomes that optimize internalization into target cells

The Regents of the University of California · Granted Tue Nov 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7135490

Method for the treatment of glomerulonephritis

Takeda Pharmaceutical Company Limited · Granted Tue Nov 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7135453

Reagents and methods for smooth muscle therapies

THE ARIZONA BOARD OF REGENTS · Granted Tue Nov 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7135192

Cationic lipid compositions targeting angiogenic endothelial cells

The Regents of the University of California · Granted Tue Nov 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7135611

Compositions and methods for characterizing and regulating Wnt pathways

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Nov 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7135176

VMP-like sequences of pathogenic Borrelia

The Board of Regents of the University of Texas System · Granted Tue Nov 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7135324

Viral recombinases, related articles, and methods of use thereof

UNIVERSITY OF CONNECTICUT · Granted Tue Nov 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7135303

Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7138384

Modulators of DNA cytosine-5 methyltransferase and methods for use thereof

The Regents of the University of California · Granted Tue Nov 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7138569

Nucleic acids encoding pseudomonas hop proteins and use thereof

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Nov 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7138237

Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen

The Regents of the University of California · Granted Tue Nov 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7138137

Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7138141

Dispersible macromolecule compositions and methods for their preparation and use

Nektar Therapeutics · Granted Tue Nov 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7138249

Screening method

Takeda Pharmaceutical Company Limited · Granted Tue Nov 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7138533

Preventives/remedies for urinary disturbance

Takeda Pharmaceutical Company Limited · Granted Tue Nov 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7141234

Imaging of drug accumulation as a guide to antitumor therapy

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7141598

Imidazole derivatives, production method thereof and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Nov 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7141671

Biphenyl derivatives

Theravance, Inc. · Granted Tue Nov 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7141661

Non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7141603

Antitumor agents

The Regents of the University of California · Granted Tue Nov 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)